Literature DB >> 12512830

Effect of schistosoma mansoni egg deposition on multiple low doses streptozotocin induced insulin dependent diabetes.

Hala S El-Wakil1, Tarek S E Aboushousha, Omkolsoum El Haddad, Nihal B Gamil, Tarek Mansour, Hany El-Said.   

Abstract

To explore the role of Schistosoma mansoni infection in the prevention of autoimmune mediated insulin dependant diabetes mellitus, we examined the effects of multiple low doses of the pancreatic islets beta cell toxin, streptozotocin (STZ) 40mg/kg body weight i.p., given 8 weeks post infection, period of S. mansoni egg deposition, on S. mansoni infected C57BL/6J mice, in comparison to non-infected STZ given group. Mice treated with STZ (G III) became gradually hyperglycemic reaching highest level on days 17 post STZ with mean blood glucose level of 334.9 +/- 14.9 vs 130.3 +/- 9.2 mg/dl in control group (G IV). S. mansoni infection (G II) significantly reduced the elevation in blood glucose levels from days 7 post STZ onwards reaching 224mg/dl +/- 12.7 on days 17 (P < .0.001). Morphologic examination of pancreas on day 21 post STZ, revealed that the non-infected STZ (G III) given mice had significantly smaller mean islets area (5,060.51 mu2 +/- 1,567.28) and significantly fewer mean number of beta cells/islets (76.23 +/- 19.18) than the infected STZ given group (G II) which had mean islets area (9,305. 3l mu2 +/- 3,277.59) and 116.75 +/- 27.27 beta-cells/islets. Pancreatic tissue revealed also focal degeneration in the cells of islets of Langrhans in the non-infected STZ given mice (G III), in comparison, to the infected STZ given group (G II). which had much less evident cells degeneration. These findings revealed that S. mansoni egg deposition which leads to a shift from Th1 (IFN-gamma mainly) to Th2 (IL4, IL5, IL10 and TGF-beta cytokine profiles causes down-regulation of the Th1 cell mediated autoimmune insulin dependant diabetes mellitus (IDDM). On the other hand, S. mansoni eggs excretions were significantly lower in the infected STZ given group (G II) than the infected group (G I). This finding may be the result of impaired maturation of egg in diabetic mice. It is concluded that the modulation of immune response in S. mansoni infected mice with S. mansoni egg deposition, can suppress the autoimmune type 1 insulin dependant diabetes mellitus induced by multiple low doses streptozotocin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12512830

Source DB:  PubMed          Journal:  J Egypt Soc Parasitol        ISSN: 1110-0583


  10 in total

1.  Filarial Abundant Larval Transcript Protein ALT-2: An Immunomodulatory Therapeutic Agent for Type 1 Diabetes.

Authors:  Sridhar M Reddy; Pooja M Reddy; Nitin Amdare; Vishal Khatri; Aaditya Tarnekar; Kalyan Goswami; Maryada Venkata Rami Reddy
Journal:  Indian J Clin Biochem       Date:  2016-06-07

Review 2.  Therapeutic potential of helminths in autoimmune diseases: helminth-derived immune-regulators and immune balance.

Authors:  Meng Wang; Linxiang Wu; Rennan Weng; Weihong Zheng; Zhongdao Wu; Zhiyue Lv
Journal:  Parasitol Res       Date:  2017-06-29       Impact factor: 2.289

3.  Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-β.

Authors:  Marc P Hübner; Yinghui Shi; Marina N Torrero; Ellen Mueller; David Larson; Kateryna Soloviova; Fabian Gondorf; Achim Hoerauf; Kristin E Killoran; J Thomas Stocker; Stephen J Davies; Kristin V Tarbell; Edward Mitre
Journal:  J Immunol       Date:  2011-12-14       Impact factor: 5.422

4.  Decreased basal non-insulin-stimulated glucose uptake by diaphragm in streptozotocin-induced diabetic mice infected with Schistosoma mansoni.

Authors:  Hala S Thabet; Nermine K M Saleh; Sahar S Thabet; M Abdel-Aziz; Nagwa K Kalleny
Journal:  Parasitol Res       Date:  2008-05-29       Impact factor: 2.289

5.  Inhibition of type 1 diabetes in filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3+ regulatory T cells.

Authors:  Marc P Hübner; J Thomas Stocker; Edward Mitre
Journal:  Immunology       Date:  2008-11-07       Impact factor: 7.397

Review 6.  Schistosome: its benefit and harm in patients suffering from concomitant diseases.

Authors:  Yoshio Osada; Tamotsu Kanazawa
Journal:  J Biomed Biotechnol       Date:  2011-11-03

7.  The association of Schistosoma and geohelminth infections with β-cell function and insulin resistance among HIV-infected and HIV-uninfected adults: A cross-sectional study in Tanzania.

Authors:  George PrayGod; Suzanne Filteau; Nyagosya Range; Kaushik Ramaiya; Kidola Jeremiah; Andrea M Rehman; Rikke Krogh-Madsen; Henrik Friis; Daniel Faurholt-Jepsen
Journal:  PLoS One       Date:  2022-01-25       Impact factor: 3.752

Review 8.  Alternatively activated macrophages in types 1 and 2 diabetes.

Authors:  Arlett Espinoza-Jiménez; Alberto N Peón; Luis I Terrazas
Journal:  Mediators Inflamm       Date:  2012-12-27       Impact factor: 4.711

9.  Immunoregulation by Taenia crassiceps and its antigens.

Authors:  Alberto N Peón; Arlett Espinoza-Jiménez; Luis I Terrazas
Journal:  Biomed Res Int       Date:  2012-12-27       Impact factor: 3.411

Review 10.  Schistosoma Infection and Schistosoma-Derived Products Modulate the Immune Responses Associated with Protection against Type 2 Diabetes.

Authors:  Chun-Lian Tang; Zhi-Ming Liu; Yan Ru Gao; Fei Xiong
Journal:  Front Immunol       Date:  2018-01-17       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.